Congressman Bilbray to Visit Accelrys Inc. Headquarters in San Diego on May 28th

SAN DIEGO, CA--(Marketwire - May 26, 2009) -

Highlighted Links

http://www.accelrys.com

Bilbray

Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific business intelligence software and services, today announced that Congressman Brian P. Bilbray, who represents the 50th Congressional District of California, will visit Accelrys headquarters in San Diego on May 28 at 3:30 p.m.

Bilbray, who is Co-Chair of the Congressional Biomedical Research Caucus and serves on the Science and Technology Committee, will tour the Accelrys facility and meet with Accelrys executives to learn about:

--  What Accelrys is doing in support of energy and Life Sciences research
--  The company's strategy of maintaining research and development on U.S.
    soil
--  The company's local contribution to the San Diego economy
--  How Accelrys is promoting science in America
    

There will be time for discussion and questions. Members of the media are invited to attend.

WHAT:       Congressman Bilbray visit to Accelrys
WHERE:      Accelrys, Inc.
            10188 Telesis Court, Suite 100
            San Diego, CA 92121
DIRECTIONS: http://accelrys.com/company/locations/directions-san-diego.html
CONTACT:    Maria Krinsky
            Kickstart for Accelrys
            (415) 509-0498
            mkrinsky@kickstartconsulting.com

For more information about Congressman Bilbray, visit http://www.house.gov/bilbray/

About Accelrys, Inc.

Headquartered in San Diego, California, Accelrys develops scientific business intelligence software and solutions for the life sciences, energy, chemicals, aerospace, and consumer products industries. Customers include many Fortune 500 companies and other commercial entities, as well as academic and government entities. Accelrys has a vast portfolio of computer-aided design modeling and simulation offerings which assist customers in conducting scientific experiments 'in silico' in order to reduce the duration and cost of discovering and developing new drugs and materials. Its scientific business intelligence platform underlies the company's computer-aided design modeling and simulation offerings. The Accelrys platform can be used with both Accelrys and competitive products, as well as with customers' proprietary predictive science products. Its flexibility, ease-of-use and advanced chemical, text and image analysis and reporting capabilities enable customers to mine, aggregate, analyze and report scientific data from disparate sources, thereby better utilizing scientific data within their organizations. For more information about Accelrys, visit http://accelrys.com/